HomeCompareVXTRQ vs JNJ

VXTRQ vs JNJ: Dividend Comparison 2026

VXTRQ yields 6666666.67% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VXTRQ wins by $8.25873857526507e+44M in total portfolio value
10 years
VXTRQ
VXTRQ
● Live price
6666666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$8.25873857526507e+44M
Annual income
$825,849,488,962,360,000,000,000,000,000,000,000,000,000,000,000,000.00
Full VXTRQ calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — VXTRQ vs JNJ

📍 VXTRQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVXTRQJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VXTRQ + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VXTRQ pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VXTRQ
Annual income on $10K today (after 15% tax)
$566,666,666.67/yr
After 10yr DRIP, annual income (after tax)
$701,972,065,618,006,100,000,000,000,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, VXTRQ beats the other by $701,972,065,618,006,100,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VXTRQ + JNJ for your $10,000?

VXTRQ: 50%JNJ: 50%
100% JNJ50/50100% VXTRQ
Portfolio after 10yr
$4.129369287632535e+44M
Annual income
$412,924,744,481,180,000,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VXTRQ
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VXTRQ buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVXTRQJNJ
Forward yield6666666.67%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$8.25873857526507e+44M$30.3K
Annual income after 10y$825,849,488,962,360,000,000,000,000,000,000,000,000,000,000,000,000.00$4,689.40
Total dividends collected$8.258722632802889e+44M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: VXTRQ vs JNJ ($10,000, DRIP)

YearVXTRQ PortfolioVXTRQ Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$666,677,367$666,666,666.67$10,592$272.30+$666.67MVXTRQ
2$41,538,243,978,220$41,537,530,633,437.17$11,289$357.73+$41538243.97MVXTRQ
3$2,418,785,178,923,619,000$2,418,740,733,002,562,000.00$12,123$472.89+$2418785178923.61MVXTRQ
4$131,632,535,180,835,430,000,000$131,629,947,080,693,970,000,000.00$13,141$629.86+$131632535180835424.00MVXTRQ
5$6,694,929,569,421,761,000,000,000,000$6,694,788,722,609,116,000,000,000,000.00$14,408$846.81+$6.69492956942176e+21MVXTRQ
6$318,233,313,948,923,370,000,000,000,000,000$318,226,150,374,284,100,000,000,000,000,000.00$16,021$1,151.60+$3.1823331394892335e+26MVXTRQ
7$14,137,160,116,927,522,000,000,000,000,000,000,000$14,136,819,607,281,600,000,000,000,000,000,000,000.00$18,122$1,588.22+$1.4137160116927522e+31MVXTRQ
8$586,942,647,681,175,100,000,000,000,000,000,000,000,000$586,927,520,919,850,000,000,000,000,000,000,000,000,000.00$20,930$2,228.20+$5.8694264768117504e+35MVXTRQ
9$22,774,359,015,829,920,000,000,000,000,000,000,000,000,000,000$22,773,730,987,196,898,000,000,000,000,000,000,000,000,000,000.00$24,792$3,191.91+$2.277435901582992e+40MVXTRQ
10$825,873,857,526,507,000,000,000,000,000,000,000,000,000,000,000,000$825,849,488,962,360,000,000,000,000,000,000,000,000,000,000,000,000.00$30,274$4,689.40+$8.25873857526507e+44MVXTRQ

VXTRQ vs JNJ: Complete Analysis 2026

VXTRQStock

Voxtur Analytics Corp. operates as a real estate technology company in the United States and Canada. The company offers ReboGateWay Pro, a live format for automatic property updates and alerts on changes within farms/lists; Title Toolbox, a tool that provides property data in a live format for automatic property updates and alerts; Investor Toolbox, an access to all property and farming tools; Lender Toolbox provides targeted data to pinpoint homeowners to exact lending program criteria for various lending options; Premier Lists, a custom data list service designed to create prospect list for a specific area; TaxExpress, a tax certificate solution; and O and E QuickCheck, a data intelligence report for real estate that evaluate loans or portfolios and close, Voxtur Verify and Data Connect. It also provides Anow SaaS Appraiser product, tool for appraisers and analysts to manage valuation orders, employees, scheduling, accounting, client communication, and reporting; Voxtur Direct, an appraisal management solution; and Reports Now, an automated report builder. In addition, the company offers AOL, a full-coverage title alternative; residential and commercial services; default to manage loan portfolio; insured title products that protect purchasers and lenders against defects in title; and uninsured title products. Further, it provides Real Property Tax Analytics for transparency and insight; ApexSketch, a line of software applications designed to build floorplan sketches; ApexSketch Portal which allow users to save Property Sketch Data; GeoViewport to aggregate visual property data into one location; StreetScape, a visual and data intelligence product; Apex Professional Services; consulting practice focused on property assessment; and technology-enabled solutions related to property tax. The company is based in London, Canada.

Full VXTRQ Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this VXTRQ vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VXTRQ vs SCHDVXTRQ vs JEPIVXTRQ vs OVXTRQ vs KOVXTRQ vs MAINVXTRQ vs ABBVVXTRQ vs MRKVXTRQ vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.